Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
RVTYRevvity Inc Live data
$151.02▼ -0.09 (-0.1%%)as of Sep 29, 2026, 1:55 AM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$81.22$152.26
Daily Price Range
Day down -0.1%%
$148.12$151.05
Volume
vs 2M avg
2M2M avg
Profile
Identity and capital structure
SectorEquity
IndustryCommon Stock
Market Cap$16.9B
Short % of Float—
Employees—
Sales—
Shares Outstanding111,640,842
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.rvty.com
Revvity Inc — Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy….· via yahoo
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for RVTY.
Price targets unavailable — no 12-month targets on file for RVTY.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on RVTY, calculate Margin of Safety, and stress-test WACC discount hurdles.
Data as ofQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedSep 29, 2026, 1:55 AM UTC